Original Article: Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer (phase 3 RASolute 302 trial) https://t.co/y4G27hfORg
#ASCO26 | @ASCO
Today marks four years since we lost my brother - a physician, away on a locums assignment. It was around 9:15 AM PST on May 21, 2022 when we last spoke. I was on my way to the gym, it felt like just another Saturday. That conversation lives with me every day. What I wouldn't give for just one more.
His passing changed how I see everything. I found myself paying closer attention to what other physicians were carrying, the quiet struggles. For a while, I felt hopeful. There was real momentum building around physician wellness, and it felt like something was finally shifting.
But the needle is moving in the wrong direction. Burnout rates remain at historic highs. Physicians are leaving clinical medicine faster than we can replace them. The administrative burden - prior authorizations, documentation, clunky EMRs, breaking the glass on a patient there to see YOU, continues to consume the hours that should be spent on patients, or on rest, or on simply being human.
Mental health stigma in medicine hasn't gone away; if anything, the fear of career consequences keeps too many physicians suffering in silence. And we lost more colleagues to suicide this year than we should ever accept as normal.
I don't have all the answers. But I know this - we have to figure it out, and we are running out of time before the profession is just a shell of itself.
Among patients with moderate or severe PTS, the addition of endovascular therapy to standard care resulted in less severe PTS and better quality of life at 6 months than standard care alone but with a higher risk of bleeding. Full phase 3 C-TRACT trial results and Research Summary: https://t.co/r2a9OzBLfw
Welcome home Reid, Victor, Christina, and Jeremy! 🫶
The Artemis II astronauts have splashed down at 8:07pm ET (0007 UTC April 11), bringing their historic 10-day mission around the Moon to an end.
🫀Excited to share research that I supervised as senior author, now published in @NatureMedicine: the largest global analysis of ischemic heart disease burden attributable to suboptimal diet to date.
As a researcher in cardiovascular epidemiology, I've always believed that what we eat is one of the most powerful levers we have for preventing heart disease. Our data now quantify just how large that lever is, and the findings are both sobering and actionable.
We assessed 13 dietary risk factors across 204 countries from 1990 to 2023. In 2023 alone, suboptimal diet was responsible for an estimated 4.06 million ischemic heart disease deaths worldwide.
Key takeaways:
1️⃣ The patterns of suboptimal diet vary substantially across the globe. While developing countries most often face ischemic heart disease burden related to undernutrition and limited access to protective foods (ie, whole grains, fruits, vegetables, omega-3 fatty acids), developed countries are more commonly burdened by overconsumption of harmful dietary components (ie, processed meats, sugar-sweetened beverages).
2️⃣Global efforts have historically targeted sodium, sugar, and fat reduction. Our data suggest that promoting the intake of whole grains, nuts, fruits, and legumes deserves equal, if not greater, priority.
Special thanks to the @IHME_UW for enabling this work and to the remarkable #GBD collaborators worldwide. It has been a privilege to supervise and work closely with Sooji Lee, Hayeon Lee, Yejun Son, Jae Il Shin, alongside Prof. Dong Keon Yon.
Paper: https://t.co/XYcv7lf5IY
#CardiovascularHealth #Diet #Nutrition #IHD #CAD #GBD #GlobalHealth #PublicHealth #HeartDisease #FoodIsMedicine
@broadinstitute | @MGBResearchNews | @MassGenBrigham | @kh_univ
Today, we’re announcing the winners of the MedGemma Impact Challenge, launched in collaboration with @Kaggle. 850+ participating teams showed us how AI can help bridge global healthcare gaps. Check out the winning innovations →https://t.co/oHd56zx28D
59 M with severe progressive lower urinary tract symptoms.
What is the diagnosis? 🧐
Answer: 🔗 https://t.co/fW3fe2yPLk
Have a companion case? Share using #CookyBites #253. We will RT the best cases!
#RGphx@cookyscan1@RadioGraphics
142,000 participants!
The largest randomized trial of a multi-cancer early detection (MCED) test failed its primary endpoint
https://t.co/epcTaGn3bn
Had the enrollment been risk-based instead of age 50, it would likely have been very positive.
🧠📝 Following up! The companion editorial, “Imaging Outcomes After MMAE for cSDH,” takes a deeper dive into how embolization shapes radiologic results. A sharp look at why MMAE is changing the game. Check it out 👇 #NeuroIR#Radiology
https://t.co/3hRbfVPP1S
The latest Cases from the Cooky Jar describes findings of Mazabraud syndrome, a rare benign disorder characterized by fibrous dysplasia and myxoid tumors. https://t.co/Lfg9pjLDm7
52 F with arm pain.
What is the diagnosis?
Answer: 🔗 https://t.co/UFlsTPL9zH
Have a companion case? Share using #CookyBites #244. We will RT the best cases!
#RGphx@cookyscan1@RadioGraphics
Thanks to all the hard work in evaluating nearly 1600 educational exhibits @RSNA from @RadioGraphics 433 and panelists and 60 editors reviewing all the incredible #RSNA2025 education exhibits . Final @RadioGraphics solicits are posted! #Gratitude#education
We loved kicking off the morning with our residents and fellows from all six of our journals' Trainee Editorial Boards!
Thank you to every trainee board member for your time, insight and dedication. You all play an important role in advancing our journals and shaping the future of radiology. We are grateful for all of you. #RadRes #RadInTraining #RSNA25 @RITEditor@radiology_rsna@RadioGraphics@RadiologyCTI@Radiology_AI@RadIC_Editor